Surgery Partners Inc (SGRY)
NASDAQ:SGRY
Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.00
$0.26(1.26%)
At close: 4:00 PM EST
$14.00
$0.26(1.26%)
Day’s Range― - ―
52-Week Range$11.41 - $24.18
Previous CloseN/A
Volume149.01K
Average Volume (3M)1.27M
Market Cap
$1.84B
Enterprise Value$2.04B
Total Cash (Recent Filing)$239.90M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Aug 04, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.61
Shares Outstanding129,419,830
10 Day Avg. Volume930,329
30 Day Avg. Volume1,267,615
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit2.66
Enterprise Value/Ebitda2.14
Forecast
1Y Price Target
$19.55Price Target Upside39.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)0.39
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Activist Campaign And Governance OverhaulActivist hedge fund's push for a board refresh and new management increases the likelihood of decisive governance changes aimed at unlocking shareholder value.
Asset Divestiture And Capital AllocationSale of the surgical hospital portfolio could generate substantial cash to fund share repurchases and pay down debt, helping improve the company's credit profile and return capital to shareholders.
Operational Cost-efficiency InitiativesExecution of cost-efficiency measures such as standardized purchasing, restructured operating room staffing, and increased use of nurse anesthetists could lower operating expenses and support margin recovery.
Bears Say
Guidance Downgrades And Cost HeadwindsLowered guidance that cites higher incentive compensation, increased provider taxes and tariffs, and excludes potential merger gains signals persistent earnings headwinds and a conservative near-term outlook.
High Leverage And Credit ConstraintsElevated debt levels limit strategic flexibility and may strain creditworthiness, making debt reduction a critical risk to address before pursuing growth moves.
Localized Market UnderperformanceUnderperformance in several surgical hospital markets, driven by physician retirements and slower-than-expected ramp of new recruits, is creating sustained pressure on volume and revenue in those regions.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc’s price range in the past 12 months?
Surgery Partners Inc lowest stock price was $11.41 and its highest was $24.18 in the past 12 months.
What is Surgery Partners Inc’s market cap?
Surgery Partners Inc’s market cap is $1.84B.
When is Surgery Partners Inc’s upcoming earnings report date?
Surgery Partners Inc’s upcoming earnings report date is Aug 04, 2026 which is in 90 days.
How were Surgery Partners Inc’s earnings last quarter?
Surgery Partners Inc released its earnings results on May 05, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.124 by $0.094.
Is Surgery Partners Inc overvalued?
According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued.
Does Surgery Partners Inc pay dividends?
Surgery Partners Inc does not currently pay dividends.
What is Surgery Partners Inc’s EPS estimate?
Surgery Partners Inc’s EPS estimate is 0.07.
How many shares outstanding does Surgery Partners Inc have?
Surgery Partners Inc has 129,419,830 shares outstanding.
What happened to Surgery Partners Inc’s price movement after its last earnings report?
Surgery Partners Inc reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.124. Following the earnings report the stock price went down -12.343%.
Which hedge fund is a major shareholder of Surgery Partners Inc?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.55 (39.64% Upside)
$19.55 (39.64% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 520.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.02%
12-Months-Change
Fundamentals
Return on Equity
-4.50%
Trailing 12-Months
Asset Growth
2.91%
Trailing 12-Months
Company Description
Surgery Partners Inc
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Neutral — The call conveyed cautious optimism: the company reported solid revenue and EBITDA in line with expectations, strong MSK/robotics momentum, physician recruiting progress and reiterated full‑year guidance, but those positives are counterbalanced by below‑trend case growth, payer mix/provider tax headwinds, rising interest expense and elevated leverage that temper near‑term upside.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$19.55
▲(39.64% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
40.28% Insiders
26.40% Mutual Funds
0.35% Other Institutional Investors
22.52% Public Companies and
Individual Investors